Upstream Bio, Inc.
UPB
$5.84
-$0.35-5.65%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -17.50% | 82.69% | 8.97% | 12.52% | 83.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -17.50% | 82.69% | 8.97% | 12.52% | 83.73% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -17.50% | 82.69% | 8.97% | 12.52% | 83.73% |
| SG&A Expenses | -4.95% | 19.20% | 29.24% | 36.27% | 86.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.73% | 37.05% | 73.91% | 97.52% | 150.88% |
| Operating Income | 4.46% | -36.24% | -75.42% | -100.25% | -152.83% |
| Income Before Tax | 0.66% | -48.85% | -99.88% | -111.03% | -172.29% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.66% | -48.85% | -99.88% | -111.03% | -172.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 0.66% | -48.85% | -99.88% | -111.03% | -172.29% |
| EBIT | 4.46% | -36.24% | -75.42% | -100.25% | -152.83% |
| EBITDA | 4.48% | -36.27% | -75.53% | -100.16% | -152.78% |
| EPS Basic | 2.11% | -46.89% | -3.00% | 88.17% | 80.66% |
| Normalized Basic EPS | 2.11% | -46.87% | -68.88% | 88.17% | 84.76% |
| EPS Diluted | 2.11% | -46.89% | -3.00% | 88.17% | 80.66% |
| Normalized Diluted EPS | 2.11% | -46.87% | -68.88% | 88.17% | 84.76% |
| Average Basic Shares Outstanding | 1.48% | 1.33% | 18.35% | 1,683.90% | 1,687.06% |
| Average Diluted Shares Outstanding | 1.48% | 1.33% | 18.35% | 1,683.90% | 1,687.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |